Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

162
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
162
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

200
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
200
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

255
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
255
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

281
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
281
Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

3.4K
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
3.4K
Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of climate change literacy in the era of global boiling: a cross-sectional survey of Egyptian nursing students.

BMC nursing·2024
Same author

Relationship between resilience and health-related quality of life among patients with a permanent colostomy.

British journal of nursing (Mark Allen Publishing)·2022
Same journal

How the introduction of a specialist triage tool in a community palliative care setting impacts referral to review time and staff wellbeing.

International journal of palliative nursing·2026
Same journal

Artificial intelligence and palliative care.

International journal of palliative nursing·2026
Same journal

Nursing outcome 'dignified life closure' in patients under palliative care.

International journal of palliative nursing·2026
Same journal

Assessing the impact of prostate cancer prevention and detection initiatives.

International journal of palliative nursing·2026
Same journal

Mindfulness-based and educational interventions for family caregivers of patients with cancer: a pilot study on self-compassion and quality of sleep.

International journal of palliative nursing·2026
Same journal

Empowering end-of-life choices: evaluation of an innovative model of integrated palliative care.

International journal of palliative nursing·2026
See all related articles

Related Experiment Video

Updated: Jun 30, 2025

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.2K

Chemosensory changes during chemotherapy.

Mona Abed El-Rahman Mohamed1, Noha Mohammed Ibrahim Ibrahim1, Hanan Hassan Elezaby2

  • 1Medical-Surgical Nursing, Faculty of Nursing Port-Said University.

International Journal of Palliative Nursing
|March 22, 2024
PubMed
Summary
This summary is machine-generated.

Chemotherapy significantly alters taste and smell, impacting cancer patients' enjoyment of food and quality of life. Specialized nutritional therapy is recommended to address these chemosensory changes during treatment.

Keywords:
chemotherapyoncology patientssmell changetaste change

More Related Videos

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
05:56

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on: June 21, 2024

783
Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

7.4K

Related Experiment Videos

Last Updated: Jun 30, 2025

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.2K
Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
05:56

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on: June 21, 2024

783
Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

7.4K

Area of Science:

  • Oncology
  • Nutrition Science
  • Sensory Science

Background:

  • Chemotherapy can cause significant chemosensory changes.
  • These alterations affect food enjoyment, quality of life, and patient recovery.

Purpose of the Study:

  • To investigate the chemosensory changes experienced by oncology patients undergoing chemotherapy.
  • To understand the impact of these changes on patients' lives.

Main Methods:

  • A mixed-method cross-sectional study involving 100 cancer patients.
  • Questionnaires assessed taste and smell preferences.
  • Semi-structured interviews explored patients' experiences with chemosensory changes.

Main Results:

  • Bitter taste alterations and changed food preferences were common.
  • Unpleasant odors, sometimes unrelated to food presence, were frequently reported.
  • Key themes included changes in taste, smell, social life, comfort, and food preferences.

Conclusions:

  • Chemosensory changes impact nutrient intake, eating behaviors, and quality of life.
  • Specialized nutritional therapy is crucial for patients experiencing chemotherapy-associated chemosensory alterations.
  • Regular evaluation of chemosensory alterations should be part of nutritional assessments.